Is a complete ELOX research report available?

No complete published report is available for Eloxx Pharmaceuticals, Inc. (ELOX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Eloxx Pharmaceuticals, Inc. (ELOX)

NASDAQ: ELOX · USD

$12.9

+0.08 (+0.6%)· Recorded snapshot

Market cap	52.2M
Net income (ttm)	-10.7M
EPS (ttm)	-$2.84
Shares out	4M
Volume	23,403.159
Beta	-169223.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -10.7M
EPS (ttm): -$2.84
Market cap: 52.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001035354
Company name	Eloxx Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	29014R301
Earnings date	2026-08-12
Earnings time	bmo
Employees	10
Employees change	-8
Employees growth	-44.44%
Enterprise value	$2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	1999
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US29014R3012
Last earnings date	2026-08-12
Last refreshed	2026-11-04
Last stock split date	2026-06-01
Last stock split type	Reverse
Market cap	$52.2M
Market cap category	Micro-Cap
Next earnings date	2027-08-11
Options	No
Price	$12.92
Price currency	USD
Sector	Healthcare
Stock price date	2026-11-03
Symbol	ELOX
U.S. state	Massachusetts
Website	https://www.eloxxpharma.com

Metric

Value

Amount currency

USD

CIK code

0001035354

Company name

Eloxx Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

29014R301

Earnings date

2026-08-12

Earnings time

bmo

Employees

Employees change

-8

Employees growth

-44.44%

Enterprise value

$2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-07-12

Fiscal year end

December

Founded

1999

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US29014R3012

Last earnings date

2026-08-12

Last refreshed

2026-11-04

Last stock split date

2026-06-01

Last stock split type

Reverse

Market cap

$52.2M

Market cap category

Micro-Cap

Next earnings date

2027-08-11

Options

Price

$12.92

Price currency

USD

Sector

Healthcare

Stock price date

2026-11-03

Symbol

ELOX

U.S. state

Massachusetts

Website

https://www.eloxxpharma.com

Metric	Value
Earnings yield	-22.01%
FCF / EV yield	-792.27%
FCF yield	-30.72%
P/B ratio	1.12x
Price / tangible book value	1.12x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-22.01%

FCF / EV yield

-792.27%

FCF yield

-30.72%

P/B ratio

1.12x

Price / tangible book value

1.12x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
Profit per employee	$-1.1M
ROA (5Y)	-79.38%
ROCE	-25.59%

Metric

Value

Profit per employee

$-1.1M

ROA (5Y)

-79.38%

ROCE

-25.59%

Metric	Value
EPS growth quarters	1
EPS growth years	4
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
EBIT	$-11.9M
EPS	$-2.84
FCF per share	$-3.97
Financing cash flow	$77.4M
Free cash flow	$-16M
Free cash flow minus SBC	$-16.4M
Investing cash flow	$1,000
Net borrowing	$300,000
Net cash flow	$61.4M
Net income	$-10.7M
Operating cash flow minus SBC	$-16.4M
Operating income	$-11.9M
Stock-based compensation	$340,000

Metric

Value

EBIT

$-11.9M

EPS

$-2.84

FCF per share

$-3.97

Financing cash flow

$77.4M

Free cash flow

$-16M

Free cash flow minus SBC

$-16.4M

Investing cash flow

$1,000

Net borrowing

$300,000

Net cash flow

$61.4M

Net income

$-10.7M

Operating cash flow minus SBC

$-16.4M

Operating income

$-11.9M

Stock-based compensation

$340,000

Metric	Value
Book value per share	$11.50
Debt / equity	0.25
Interest coverage	-40.41
Long-term assets	$0
Long-term liabilities	$0
Net cash (debt)	$50.1M
Net cash / market cap	96.12%
Net debt / equity	-1.08
Piotroski F-Score	1
Shareholders' equity	$46.4M
Tangible book value	$46.4M
Tangible book value per share	$11.50
Total assets	$63.4M
Total cash	$62M
Total debt	$11.8M
Total liabilities	$17M
WACC	-758,623.01%

Metric

Value

Book value per share

$11.50

Debt / equity

0.25

Interest coverage

-40.41

Long-term assets

Long-term liabilities

Net cash (debt)

$50.1M

Net cash / market cap

96.12%

Net debt / equity

-1.08

Piotroski F-Score

Shareholders' equity

$46.4M

Tangible book value

$46.4M

Tangible book value per share

$11.50

Total assets

$63.4M

Total cash

$62M

Total debt

$11.8M

Total liabilities

$17M

WACC

-758,623.01%

Metric	Value
Current assets	$63.4M
Current liabilities	$17M
Current ratio	3.74
Net working capital	$-3.7M
Quick ratio	3.65
Working capital	$46.4M

Metric

Value

Current assets

$63.4M

Current liabilities

$17M

Current ratio

3.74

Net working capital

$-3.7M

Quick ratio

3.65

Working capital

$46.4M

Metric	Value
Buyback yield / dilution	-1,502.77%
Dividend yield	0%
Shareholder yield	-1,502.77%

Metric

Value

Buyback yield / dilution

-1,502.77%

Dividend yield

Shareholder yield

-1,502.77%

Metric	Value
150-day SMA	$10.73
1D price change	0.62%
1M price change	-16.7%
1M total return	-16.7%
1W price change	-3.15%
1W total return	-3.15%
1Y price change	1,174,445.46%
1Y return CAGR	1,183,085.05%
1Y total return	1,175,514.2%
20-day SMA	$13.32
200-day SMA	$8.04
3M price change	-25.87%
3M total return	-25.87%
3Y price change	-1.3%
3Y return CAGR	-0.43%
3Y total return	-1.3%
50-day SMA	$15.04
50-day SMA vs 200-day SMA	50over200
52-week high	$23.40
52-week high date	2026-08-21
52-week low	$0.00
52-week low date	2025-12-02
5Y price change	-97.97%
5Y return CAGR	-54.16%
5Y total return	-97.97%
6M price change	518.18%
6M total return	518.18%
After-hours change	0.08%
After-hours close	$12.92
After-hours price	$12.93
All-time high	$10,824.00
All-time high date	2018-06-15
All-time low	$0.00
All-time low date	2024-08-14
Average true range (ATR)	$1.26
Average volume	25.3K
Beta (1Y)	-2,297.1
Beta (2Y)	-2,708.85
Beta (5Y)	-169,223.47
Change from 52-week high	-44.79%
Change from 52-week low	129,199,900%
Change from all-time high	-99.88%
Change from all-time low	129,199,900%
Change from open	-1%
Day's gap	1.64%
Dollar volume	$302,369
High price	$13.76
Low price	$12.76
Monthly RSI	42.16
Open price	$13.05
Position in 52-week range	16%
Premarket change	2.55%
Premarket close	$12.92
Premarket price	$13.25
Previous close	$12.84
Price vs 150-day SMA	20.47%
Price vs 20-day SMA	-2.97%
Price vs 200-day SMA	60.62%
Price vs 50-day SMA	-14.08%
Relative volume	0.93
RSI	41.98
Sharpe ratio	2.47
Sharpe ratio (3Y)	1.55
Sharpe ratio (5Y)	1.2
Sortino ratio	617.7
Sortino ratio (3Y)	415.92
Sortino ratio (5Y)	316.72
Volume	23.4K
Weekly RSI	53.3
YTD price change	1,174,445.46%
YTD total return	1,175,514.2%

Metric

Value

150-day SMA

$10.73

1D price change

0.62%

1M price change

-16.7%

1M total return

-16.7%

1W price change

-3.15%

1W total return

-3.15%

1Y price change

1,174,445.46%

1Y return CAGR

1,183,085.05%

1Y total return

1,175,514.2%

20-day SMA

$13.32

200-day SMA

$8.04

3M price change

-25.87%

3M total return

-25.87%

3Y price change

-1.3%

3Y return CAGR

-0.43%

3Y total return

-1.3%

50-day SMA

$15.04

50-day SMA vs 200-day SMA

50over200

52-week high

$23.40

52-week high date

2026-08-21

52-week low

$0.00

52-week low date

2025-12-02

5Y price change

-97.97%

5Y return CAGR

-54.16%

5Y total return

-97.97%

6M price change

518.18%

6M total return

518.18%

After-hours change

0.08%

After-hours close

$12.92

After-hours price

$12.93

All-time high

$10,824.00

All-time high date

2018-06-15

All-time low

$0.00

All-time low date

2024-08-14

Average true range (ATR)

$1.26

Average volume

25.3K

Beta (1Y)

-2,297.1

Beta (2Y)

-2,708.85

Beta (5Y)

-169,223.47

Change from 52-week high

-44.79%

Change from 52-week low

129,199,900%

Change from all-time high

-99.88%

Change from all-time low

129,199,900%

Change from open

-1%

Day's gap

1.64%

Dollar volume

$302,369

High price

$13.76

Low price

$12.76

Monthly RSI

42.16

Open price

$13.05

Position in 52-week range

16%

Premarket change

2.55%

Premarket close

$12.92

Premarket price

$13.25

Previous close

$12.84

Price vs 150-day SMA

20.47%

Price vs 20-day SMA

-2.97%

Price vs 200-day SMA

60.62%

Price vs 50-day SMA

-14.08%

Relative volume

0.93

RSI

41.98

Sharpe ratio

2.47

Sharpe ratio (3Y)

1.55

Sharpe ratio (5Y)

1.2

Sortino ratio

617.7

Sortino ratio (3Y)

415.92

Sortino ratio (5Y)

316.72

Volume

23.4K

Weekly RSI

53.3

YTD price change

1,174,445.46%

YTD total return

1,175,514.2%

Metric	Value
Float	932.6K
Float percentage	23.1%
Shares change (QoQ)	54.91%
Shares change (YoY)	1,502.77%
Shares held by insiders	3.84%
Shares held by institutions	13.73%
Shares outstanding	4M
Short % of float	4.43%
Short % of shares	1.02%
Short ratio	1.7 days

Metric

Value

Float

932.6K

Float percentage

23.1%

Shares change (QoQ)

54.91%

Shares change (YoY)

1,502.77%

Shares held by insiders

3.84%

Shares held by institutions

13.73%

Shares outstanding

Short % of float

4.43%

Short % of shares

1.02%

Short ratio

1.7 days

Eloxx Pharmaceuticals, Inc. (ELOX)

Price

Financial snapshot

Fair-value bridge

Latest news · ELOX

Valuation

Balance sheet

Trading

Next earnings

Sector percentile context

All ELOX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ELOX

Frequently asked questions